51 ASTOR PLACE, 10TH FLOOR, NEW YORK, NY
Financial Results, Press Release
Election of Directors at Adagio Medical Holdings Annual Meeting
Board Expansion and Appointment of Sean Salmon as Director
Reports Third Quarter 2025 Results
Annual Report to Security Holders
Shareholder Director Nominations
Closes Financing of $19 Million Upfront; Positions to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia
Announces Pricing of up to Approximately $50 Million Private Placement of Securities
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
S-8 POS
Post-Effective Amendment to Registration Statement